A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns

Inclusion Criteria: * Subject with a partial-thickness (superficial, deep or mixed) second degree burn from 1-25% TBSA * Study site is from 1-15% BSA * Study site is a single, isolated burn area * From 2 years and above * Thermal burn injury * Signed Informed Consent/Assent Form * Subjects who are younger than the legal consenting age must in addition to their own Assent form have a signature from a legally authorized representative. Exclusion Criteria: * Completely non-exuding or dry wound bed at study site * Full thickness \>5% * Burn greater than 24 hrs old * Burns to face or neck * Suspicion of infection of study burn * Use of chemical/enzymatic and biological debridement within 7 days of investigation start * Chronic steroid use, hx of skin malignancy or chronic papulosquamous disease (e.g. eczema, Pemphigus) and hx of Steven Johnson or TENS disease * Subject with lung injury or subject being on a ventilator * Subject with dermatologic skin disorders or necrotizing processes * Subject with insulin dependent diabetes mellitus * Electrical, chemical etiology * Diagnosed underlying disease(s) (e.g. HIV/AIDS, cancer and severe anaemia), judged by the investigator to be a potential interference in the treatment * Non-compliant subject * Subject previously included in this investigation * Subject included in other ongoing clinical investigation at present or during the past 30 days.